SCHEMBL7082882

SCHEMBL7082882

c1ccc2c(c1)ccc1c3ccccc3n(-c3ccc(N(c4ccc(-n5c6ccccc6c6ccc7ccccc7c65)cc4)c4ccc(-n5c6ccccc6c6ccc7ccccc7c65)cc4)cc3)c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HPRT1 P00492 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP2A6 P11509 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ F2 P00734 1/20 0.32
▸ F10 P00742 1/20 0.32
▸ PRSS1 P07477 1/20 0.32
▸ MAPK8 P45983 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ SIGMAR1 Q99720 1/20 0.31
▸ DUSP3 P51452 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24948237 0.97 KDM4E (0.44) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL15138104 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL15894201 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL22925491 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL15138028 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL15138114 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL18232205 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL15894203 0.93 L3MBTL1 (0.41) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL24374338 0.92 L3MBTL1 (0.40) KDM4EATML3MBTL1HPRT1ALOX5
SCHEMBL15894195 0.92 L3MBTL1 (0.40) KDM4EATML3MBTL1HPRT1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186077-A1 Bis- and tris- (di) benzocarbazole-based materials as hole transport materials for organic light emitting devices CANON KABUSHIKI KAISHA (JP) 2003-10-02 — — US claimed
US-20030186077-A1 Bis- and tris- (di) benzocarbazole-based materials as hole transport materials for organic light emitting devices CANON KABUSHIKI KAISHA (JP) 2003-10-02 — — US disclosed
WO-2003059014-A1 BIS- AND TRIS-(DI)BENZOCARBAZOLE-BASED MATERIALS AS HOLE TRANSPORT MATERIALS FOR ORGANIC LIGHT EMITTING DEVICES CANON KABUSHIKI KAISHA (JP) 2003-07-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186077-A1 Bis- and tris- (di) benzocarbazole-based materials as hole transport materials for organic light emitting devices ARNT, AHR, HBS1L KDM4E 2395/4885ATM 3865/4885L3MBTL1 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback